Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Nonalcoholic Fatty Liver Disease (NAFLD), the Metabolic Disorder Par Excellence"
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Cell Metabolism".
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 3400
Special Issue Editor
Interests: NAFLD-MAFLD; cirrhosis; hepatocellular carcinoma; metabolic syndrome; insulin resistance; sex differences
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Molecular Sciences: Metabolic Associated Fatty Liver Disease (MAFLD) Research 2020-2021
Topical Collection in Metabolites: Insulin Resistance in the 2020's
Special Issue Information
NAFLD, recently renamed MAFLD, is a common condition that places a heavy burden on public health and exacts a major clinical and financial toll on a worldwide basis. Although it has been the subject of ever-increasing clinical and research interest over the last 40 years, this condition remains enigmatic as to its development and progression in the individual patient. Noninvasive diagnostic protocols are still to be validated, and optimal management options still remain to be identified. On these grounds, Metabolites (ISSN 2218-1989, 2019 IF: 4.097) intends to publish a Special Issue entitled “NAFLD, the Metabolic Disorder Par Excellence” and has approached me to serve as Guest Editor.
Potential topics include but are not limited to the following:
- Lessons from epidemiology;
- Sex differences in NAFLD;
- Lean NAFLD;
- Modifiers of the natural history of NAFLD;
- NAFLD in children, adolescents and elderly people;
- NAFLD as a systemic disorder;
- Molecular and clinical bases of NAFLD physiopathology;
- Role of the gut–liver axis in the development and progression of disease;
- Cardio-nephrometabolic risk in people with NAFLD;
- The bidirectional association of NAFLD with the metabolic syndrome;
- NAFLD secondary to endocrine disorders;
- Personalized medicine as applied to NAFLD;
- Ethics in NAFLD research;
- Role of industry-sponsored research in NAFLD;
- NAFLD and SARS-CoV-2 infection;
- Updates in diagnosis and management;
- Impact of genetics and molecular biology on clinical practice;
- Implications of novel terminology and definitions.
Dr. Amedeo Lonardo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.